Deregulated apoptosis of MCs (mesangial cells) is associated with a number of kidney diseases including end-stage diabetic nephropathy. Cell death by apoptosis is a tightly orchestrated event, whose mechanisms are not completely defined. In the present study we show that the uPA (urokinase-type plasminogen activator)/uPAR (uPA receptor) system can initiate both cell survival and pro-apoptotic signals in human MCs in response to different apoptotic stimuli. uPA abrogated MC apoptosis induced by serum withdrawal conditions and enhanced apoptosis initiated in MCs by high glucose. Effects of uPA were independent of its proteolytic activity and required uPAR for both pro-and anti-apoptotic effects. Studies on the uPAR interactome provide evidence that the opposing effects of uPA were directed via different uPAR-interacting transmembrane partners. Exposure of MCs to RGD (Arg-Gly-Asp) peptide led to abrogation of the anti-apoptotic effect of uPA, which implies involvement of integrins in this process. A pro-apoptotic effect of uPA under high-glucose conditions was mediated via association of uPAR and the cation-independent M6P (mannose-6-phosphate)/IGF2R (insulin-like growth factor 2 receptor). Both receptors were coprecipitated and co-localized in MCs. Studies on the underlying signalling indicate that the ERK1/2 (extracellular-signalregulated kinase 1/2), Akt and BAD (Bcl-2/Bcl-X L -antagonist, causing cell death) protein were involved in regulation of apoptosis by uPA in MCs. M6P/IGF2R mediated BAD perinuclear localization during apoptosis initiated by uPA and high glucose.
INTRODUCTION
One of the major consequences of diabetes is the end-stage renal failure associated with expansion of mesangial extracellular matrix and increased proliferation of MCs (mesangial cells) [1] . Apoptosis of MCs is believed to play a critical role in the regulation of these processes [2] . The underlying molecular mechanisms, although being intensively investigated, still remain uncertain. Previous findings coming from in vitro, in vivo and clinical studies point to the important role of the fibrinolytic uPA (urokinase-type plasminogen activator)/uPAR (uPA receptor) system in kidney diseases including diabetes-related end-stage renal failure [3, 4] . uPAR is supposed to be involved in the prevention of renal fibrosis in obstructive nephropathy [5] . Up-regulation of uPA and uPAR were shown in crescentic glomerulonephritis and in a murine model of nephrotoxic nephritis respectively [6, 7] . Diabetic rats exhibited high levels of expression of uPA and uPAR, mainly in MCs, that was associated with mesangial expansion [8] . However, there is no data on the involvement of the uPA/uPAR system in regulation of MC apoptosis and underlying mechanisms have not yet been clarified.
A body of evidence shows that the uPA/uPAR system can protect cells from undergoing apoptotic cell death [9] . Nontransformed human retinal pigment epithelial cells pre-exposed to uPA exhibited reduced susceptibility to anoikis and UVinduced apoptosis through the activation of the MEK [MAPK (mitogen-activated protein kinase)/ERK (extracellular-signalregulated kinase) kinase]/ERK and PI3K (phosphoinositide 3-kinase)/Akt survival pathways [10] . Simultaneous downregulation of uPAR and uPA in SNB19 human glioma cells activated caspase-mediated apoptosis [11] . When uPAR was inhibited in different metastatic cell lines, the expression of members of the Bcl-2 family (Bax, Bcl-2, Bak and Bcl-X L ) was changed in a pro-apoptotic manner [12] . In contrast, several previous findings documented a pro-apoptotic role of uPA and uPAR in cellular physiology. Thus a negative effect of uPA on cell survival has been observed in a mouse model of retinal damage [13] . Cleaved high-molecular-mass kininogen via binding to uPAR induced apoptosis of human endothelial cells, most probably due to changes in uPAR association with other signalling components [14] . Taken together, these results suggest multifunctional properties of the uPA/uPAR system in survival/apoptosis processes. Since uPAR is linked to the outer membrane leaflet by a GPI (glycosylphosphatidylinositol)-anchor, all of its diverse biological functions are strictly dependent on its interactions with other proteins. However, the important question, whether cell survival or apoptotic response to uPA may be determined by the composition of the uPAR signalling receptor complex, has not so far been addressed.
In the present study, we investigated the effect of uPA on apoptosis of human MCs under HG (high-glucose) and growth factor withdrawal conditions. We demonstrate that uPA can initiate both cell survival and apoptotic signals depending on the apoptotic stimulus. Our results indicate that the pro-apoptotic effect of uPA requires interaction of uPAR with the cationindependent M6P (mannose-6-phosphate)/IGF2R (insulin-like growth factor 2 receptor), whereas the anti-apoptotic action of uPA is mediated by integrins. Thus the uPA/uPAR signals are transduced through two mechanisms with the apoptotic stimulus acting as the switch.
EXPERIMENTAL

Cell culture
Primary human MCs were obtained from Lonza. The cells were cultured in a medium recommended by the supplier and were used at passages 6 and 7. Cells were serum-starved for 24 h followed by incubation with 10 nM uPA [or with 10 nM ATF (N-terminal fragment of uPA), where indicated] in combination with SF (serum-free) medium or with HG medium containing 30 mM D-glucose for the indicated times. In some experiments cells were pre-treated with 10 μM RGD (Arg-Gly-Asp) peptide from Bachem, with 4 mM M6P obtained from Sigma, with 0.4 μg/ml neutralizing polyclonal anti-uPAR antibody from R&D Systems or with 1 mM EDTA (Roth). Human uPA (predominately of the high-molecular-mass form, 100 000 international units, 1 mg/ml) was purchased from Loxo and ATF of human uPA (1 mg/ml) was from Innovative Research. For apoptosis detection the cells were stained with Hoechst 33258 (Sigma).
Apoptosis detection
Hoechst 33258 staining assay
MCs were seeded on to glass coverslips in 12-well plastic plates (Nunc) and cultured in standard culture medium (MsBM; Lonzo). After 24 h starvation, the cells were treated as described above for 24-72 h. Cells in culture medium were used as a NC (negative control) for apoptosis. D-Mannitol was used as an osmotic control. The cells were fixed with 4 % (w/v) paraformaldehyde in PBS (pH 7.4) for 10 min, washed with PBS, stained with 2 μg/ml Hoechst 33258 for 30 min at 37
• C and embedded in Vectashield mounting medium (Vector Laboratories). The cells were observed, under a Leica DM LB fluorescence microscope (Leica Microsystems), equipped with a 40× objective, by the observer blind to the cell treatment. The nuclei stained with Hoechst 33258 that were markedly bright and small or divided into several homologous chromatin clumps, were defined as being condensed or fragmented nuclei respectively. Cells from ten random microscopic fields of view at 400× magnification were counted per coverslip and the average percentage of apoptotic cells was calculated.
TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling) assay MC apoptosis was examined with the commercially available DeadEnd TM Fluorometric TUNEL System (Promega) following the manufacturer's protocol. Subsequently, fluorescence microscopy (Leica Microsystems) analyses were performed. Cells from ten random microscopic fields of view were counted per coverslip.
Caspase 3/7 activity assay Caspase 3/7 activity was determined using a Caspase-Glo TM 3/7 assay (Promega) according to the manufacturer's protocol.
Preparation of the mitochondrial fraction
Pure mitochondrial preparations from uninfected MCs and crude mitochondrial preparations from MCs infected with lentivirus were obtained as described previously [15, 16] .
Immunoprecipitation and Western blotting
For immunoprecipitation, subconfluent serum-starved MCs were treated with stimuli as described above for 50 min at 37
• C, lysed and precleared. Precleared cell lysates containing 1.3-1.7 mg of total protein were incubated for 2 h with appropriate antibodies and then overnight at 4
• C with protein A/G PLUS-agarose. Precipitates were washed in PBS buffer containing inhibitor cocktail and were subjected to SDS/PAGE. For Western blotting the proteins were transferred on to PVDF membrane (Roche Diagnostics). Membranes were probed with appropriate antibodies followed by incubation with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology). The immune complexes were visualized by an enhanced chemiluminescence detection system (PerkinElmer Life Sciences). Chemiluminescent images were captured using VersaDoc-3000 (Bio-Rad Laboratories) and quantified using Quantity One software (Bio-Rad Laboratories).
The following primary monoclonal antibodies were used: antiuPAR clone R3 (Monozyme), anti-uPAR antibody recognizing domains D2 + D3 (American Diagnostica), anti-diphospho-ERK1/2 (Sigma), anti-ERK and anti-BAD (Bcl-2/Bcl-X Lantagonist, causing cell death; Transduction Laboratories), anti-β-tubulin (BD Biosience Pharmingen), anti-ATP synthase β-chain (Molecular Probes) and anti-Bcl-2 antibody (DakoCytomation). The primary polyclonal antibodies were: anti-M6P/IGF2R (AF2447; R&D Systems), anti-M6P/IGF2R (H-300; Santa Cruz Biotechnology), anti-phospho-Akt (Ser473) (193H12) and antiAkt (Cell Signaling Technology), and anti-Bcl-X s/L (Santa Cruz Biotechnology). The following secondary antibodies were used: Alexa Fluor ® 488-conjugated donkey anti-goat and Alexa Fluor ® 594-conjugated goat anti-mouse antibodies (Molecular Probes), and peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology). Normal rabbit IgG and normal mouse IgG were from Upstate Biotechnology.
Lentiviral vector production and cell infection
Lentiviral siRNA (small interfering RNA) vectors were designed and cloned as described previously [17] . Lentiviral vectors were produced by transient transfection of HEK (human embryonic kidney)-293T cells using an established procedure [18] . MCs were infected in the presence of 8 μg/ml polybrene with viruses at 10 8 transducing units/ml and used for experiments 3 days after infection. Under these conditions, 95 % of cells have been shown to be infected.
Cell transfection
Human primary MCs were transfected using Nucleofector TM (Amaxa Biosystems). The Basic Primary Smooth Muscle cell nucleofector kit (Amaxa Biosystems) was used according to the manufacturer's instructions. Briefly, the cells were resuspended in the nucleofector solution. Cell suspension (100 μl) at a density of 5 × 10 5 -1 × 10 6 /ml mixed with 5 μl of 10 μM siRNA were transferred to a cuvette and nucleofected with the A-33 program of an Amaxa nucleofector apparatus. The cells were immediately transferred into wells of a 12-well plate containing culture medium pre-warmed to 37
• C. Cells treated with non-specific RNA were used as a control. MCs were used for experiments at day 3 after nucleofection.
Surface-labelling of receptors and immunofluorescence confocal microscopy
Cells were seeded and cultured on glass coverslips. Serumstarved MCs were treated for 15 min with 10 nM uPA in combination with HG medium or with SF medium. After stimulation, cells were washed with PBS and incubated with anti-uPAR monoclonal antibodies and anti-M6P/IGF2R polyclonal antibody in 0.1 % (w/v) sodium azide with 1 % (w/v) BSA solution to prevent internalization at 4
• C for 15 min. Cells were washed with ice-cold PBS and incubated with Alexa Fluor ® 594-conjugated and Alexa Fluor ® 488-conjugated secondary antibodies respectively in sodium azide solution at 4
• C for 15 min and fixed in methanol at − 20
• C for 2 min. After fixation, cells were embedded in Poly-Mount mounting medium (Polysciences). The fluorescence cell images were captured using a Leica TCS-SP2 AOBS confocal microscope (Leica Microsystems). The images were taken with an oil-immersed 63 × objective, NA = 1.4 under the same microscope tuning. For evaluation analysis, the immunocytochemical images were transformed to greyscale colour mode and the staining intensity of cells was quantified using Quantity One software (Bio-Rad Laboratories). For each sample, six images from three independent experiments were analysed.
ELISA
ELISA kits for human uPA and PAI-1 (plasminogen-activator inhibitor 1) were purchased from American Diagnostica and R&D Systems respectively. uPA and PAI-1 contents in conditioned medium of MCs treated as described above were measured for 24, 48 and 72 h according to the manufacturer's instructions.
Statistical analysis
Values are presented as means + − S.E.M. Statistical analysis was performed using a Student t test. P < 0.05 was considered significant.
RESULTS
uPA elicits anti-and pro-apoptotic effects in MCs under different apoptotic conditions
To investigate a role of the uPA/uPAR system in apoptosis of MCs, we first examined whether addition of uPA could influence apoptosis induced by two different stimuli: SF medium and HG medium. The results of Hoechst 33258 staining showed that both stimuli induced apoptosis in MCs within 24-72 h of cell treatment in a time-dependent manner. The addition of uPA abrogated apoptosis induced in MCs by SF medium. In contrast, uPA in combination with HG medium resulted in a 1.8-fold increase of apoptosis in comparison with that induced by HG medium alone ( Figure 1A ). These opposing effects of uPA were confirmed by TUNEL staining ( Figure 1B ) and by measurement of caspase 3/7 activity ( Figure 1C ). These results indicate that uPA can elicit both pro-apoptotic and anti-apoptotic effects on MCs under different conditions. 
ERK1/2, Akt and BAD are downstream molecules mediating the effects of uPA
The results presented above suggest that uPA might activate different signalling pathways under different apoptotic conditions. Therefore we investigated the effect of uPA on phosphorylation of ERK1/2 and Akt, the key pathways in the regulation of a balance between apoptosis and survival [19] . Since rapid changes in phosphorylation of these kinases preceding downstream apoptotic events have been reported [20, 21] , we examined ERK1/2 and Akt after 15-20 min and 3 h of MC stimulation. A 2.1-fold increase in phosphorylation of ERK1/2 was observed after 15 min uPA stimulation in SF medium; this effect remained significant, although less pronounced after 3 h. In contrast, when we added uPA to HG medium, an inhibition of ERK1/2 phosphorylation was detected, which was more pronounced after 3 h cell stimulation (Figure 2A ). Similar effects were observed for Akt phosphorylation ( Figure 2B ). High phosphorylation levels of ERK1/2 and Akt in normal culture medium containing 5 % (v/v) FCS (foetal calf serum), used as a negative control for apoptosis, was detected (results not shown). We observed no changes in the regulation of the p38-MAPK previously reported to mediate apoptosis in other cell types [22] . Taken together, these results indicate that the ERK1/2 and Akt, but not the p38, pathway might mediate the regulation of apoptosis by uPA in MCs.
We next asked which proteins might be involved as downstream mediators of the effects of uPA on apoptosis in MCs. We addressed the Bcl-2 family of proteins, which play a key role in apoptotic events [23] . We did not find any difference in the protein level of Bcl-2 and Bcl-X s/L , the anti-apoptotic members of that group (results not shown), and finally analysed the proapoptotic BAD protein. Although no changes in short or longterm BAD phosphorylation were found in these experiments, we observed an increase of BAD protein in the mitochondrial fraction of MCs under uPA/HG conditions after 48-72 h cell stimulation ( Figure 2C ). In response to uPA/SF, BAD content was decreased, thus supporting our results on the anti-apoptotic function of uPA under these conditions. These results suggest a requirement for the BAD protein downstream of ERK1/2 and Akt in the induction of the uPA-mediated effects on MC apoptosis/survival.
uPAR is involved in both cell survival and apoptotic effects of uPA
To determine the role of uPAR in uPA-directed apoptosis of MCs, cells with down-regulated uPAR expression (LV-siuPAR MCs) were used ( Figure 3A) . Activation of both ERK1/2 and Akt was strictly dependent on uPAR, since down-regulation of uPAR prevented phosphorylation of both kinases. Consequently, siuPAR cells demonstrated negligible changes in the amount of BAD in cell mitochondrial fractions in response to uPA under different apoptotic conditions. These results suggest a direct role of uPAR in controlling both pro-and anti-apoptotic effects of uPA. The increased basal level of BAD protein was observed in MCs with down-regulated uPAR that can illustrate an important regulating role for uPAR in the apoptotic process.
Effects of uPA are independent of its proteolytic activity
To exclude any effect of proteolytic activity of uPA on apoptosis of MCs, the N-terminal fragment of uPA, devoid of any catalytic activity but still binding to uPAR with a high affinity, was used for cell treatment. The results of Hoechst 33258 staining indicate that the effects of ATF on apoptosis of MCs were identical with those of uPA ( Figure 3B ). Thus addition of ATF to HG medium resulted in a 1.6-fold increase of apoptosis as compared with apoptosis induced by HG medium alone. In contrast, ATF decreased by 2-fold apoptosis that had been initiated by growthfactor withdrawal. To exclude a possible influence of changes in endogenous uPA and PAI-1 in MCs on the observed effects, the extracellular concentration of uPA and PAI-1 was determined by means of specific ELISA for different time points (24, 48 and 72 h). Although a moderate time-dependent increase in PAI-1 and uPA was observed within 72 h, no changes in uPA and PAI-1 concentration were found in response to HG medium and serum deprivation.
The anti-apoptotic effect of uPA is mediated by integrins
In various cell types uPAR has been shown to associate functionally with different integrins [24] . Integrin-mediated adhesion has been reported to support cell survival by signalling downstream of ERK1/2 [25] . To check whether integrins might be involved in the uPA/uPAR-directed anti-apoptotic effect in MCs, cells were pre-treated with RGD peptide that could mimic cell-adhesion proteins and bind to integrins. This treatment had a negligible effect on the HG-and uPA/HG-induced apoptosis, as shown by Hoechst 33258 staining (Figure 4) . SF medium-induced apoptosis was independent of integrins. At the same time, RGD completely abrogated the pro-survival effect of uPA on the SF medium-induced apoptosis.
The pro-apoptotic, but not the survival, effect of uPA requires the uPAR interaction with M6P/IGF2R
Reports on the involvement of M6P/IGF2R in apoptotic events and its ability to interact with uPAR [26] prompted us to suggest that the binding of uPAR to M6P/IGF2R might be involved in the pro-apoptotic effect of uPA in MCs. We performed co-immunoprecipitation using an anti-M6P/IGF2R antibody using MCs stimulated with uPA under different apoptotic conditions. In all immunoprecipitates we observed a basal signal for uPAR that could indicate a constitutively presented uPAR-M6P/IGF2R complex in MCs. However, the interaction between uPAR and M6P/IGF2R in uPA/HG-treated MCs was significantly enhanced in comparison with cells treated with HG only. uPAR-M6P/IGF2R association under SF conditions without and with uPA remained at the basal level ( Figure 5A ). To check the specificity of this interaction for the uPA/HG-initiated cellular events, several experimental settings have been performed ( Figure 5A ). MCs were pre-treated with M6P, a natural ligand for M6P/IGF2R. This treatment completely abrogated formation of the uPAR-M6P/IGF2R complex. To verify a role of uPAR in this association, cells were pre-treated with a uPAR-blocking antibody. The uPA-induced association of M6P/IGF2R-uPAR was abrogated in this case. These results, together with the observation that RGD peptide blocked the uPA-induced cell survival effect, suggested that anti-and pro-apoptotic functions of uPA under different conditions might be mediated via the uPAR association with two different transmembrane signalling proteins, namely integrins or M6P/IGF2R. Therefore to test whether uPAR association with integrins was specific for the uPA anti-apoptotic action, integrin targeting was finally performed using cell treatment with EDTA. As shown in Figure 5 (A), this treatment did not affect the uPAR-M6P/IGF2R association under HG and uPA/HG conditions. At the same time, the uPAR-M6P/IGF2R association in response to uPA under SF conditions, which was otherwise non-significant, was increased after EDTA treatment. These results support the results of our experiments with RGD peptide and show that the anti-apoptotic effect of uPA initiates a uPAR-integrin association. They further imply that if integrins are blocked, a corresponding 'pool' of uPAR remains unbound and might therefore interact with other adaptor proteins on the cell surface including M6P/IGF2R. Taken together, these results confirm our (A) Quiescent MCs were left untreated or were pre-treated at 37 • C with 4 mM M6P for 1 h, with 0.4 μg/ml anti-uPAR polyclonal antibody for 1 h, with 1 mM EDTA for 30 min followed by incubation with 10 nM uPA in combination with HG or with SF medium for 50 min at 37 • C. An anti-M6P/IGF2R antibody was used to co-immunoprecipitate uPAR from cell lysates. The immunoprecipitates were analysed with an anti-uPAR antibody (upper panel). The lower panel represents statistical analysis of three independent experiments. *P < 0.05 and **P < 0.01 compared with the NC; # P < 0.05 and ## P < 0.01 compared with treatment without uPA. (B) Double-immunofluorescence surface-labelling for uPAR (first row), for M6P/IGF2R (second row) and merge image (third row) in MCs after stimulation with 10 nM uPA in combination with HG or with SF medium for 15 min. Immunofluorescence surface-labelling for M6P/IGF2R in MCs with down-regulated uPAR is presented in the fourth row. Cells in 5 % (v/v) FCS containing culture medium were used as a NC. Shown are the representative images of three independent experiments.
conclusion that pro-and anti-apoptotic effects of uPA utilize the uPAR association with different interacting partners.
In a parallel set of experiments shown in Figure 5 (B), we further investigated an association between uPAR and M6P/IGF2R using immunocytochemistry. The amount of uPAR on the cell surface was invariant under different conditions used, and the amount of M6P/IGF2R on the cell surface on MCs incubated in SF medium without and with uPA was marginal. HG up-regulated M6P/IGF2R on the cell surface and initiated partial co-localization of M6P/IGF2R and uPAR, which was further increased in response to uPA. Interestingly, cell surface presentation of M6P/IGF2R was dependent on uPAR, since downregulation of uPAR in MCs by means of siRNA resulted in an increase in M6P/IGF2R. Moreover, addition of different apoptotic stimuli did not affect the M6P/IGF2R receptor in these cells ( Figure 5B, bottom row) . These results confirm the requirement of a uPAR-M6P/IGF2R interaction for the pro-apoptotic effect of uPA and suggest an important role of uPAR in the regulation of M6P/IGF2R.
M6P/IGF2R regulates BAD translocation to nuclear membranes during apoptosis
Recent reports emphasize the importance of intracellular redistribution of proteins associated with apoptotic events [27, 28] . In particular, their perinuclear localization as a requirement for the final apoptotic steps has been suggested [27] . Since we found that BAD protein serves as a downstream effector molecule in the uPA/uPAR/M6P/IGF2R-initiated apoptotic events in MCs, we next examined changes in BAD intracellular locations under different experimental conditions ( Figure 6 ). Treatment of control cells with SF medium resulted in the formation of perinuclear aggregations of BAD protein together with mitochondria. Addition of HG aggravated the BAD protein clustering around the nuclei. Redistribution of BAD was mostly pronounced in cells treated with the uPA/HG combination. In contrast, MCs treated with uPA/SF medium revealed no BAD protein translocation. When M6P/IGF2R was down-regulated in MCs (siM6P/IGF2R), no change in the distribution of BAD in response to uPA/HG was observed. These results rule out a primary role for M6P/IGF2R in propagation of a pro-apoptotic signal in MCs. They further suggest that the association of uPAR with pro-apoptotic adaptor proteins on the cell surface might lead to a deep change in mitochondria, their intracellular redistribution and perinuclear accumulation, together with related proteins, and finally to cell death.
DISCUSSION
Despite a central role of MCs in the regulation of glomeruliassociated kidney diseases [29] , remarkably little is known of the mechanisms by which survival and apoptosis of MCs are mediated. In the present study, we provide convincing evidence that uPA, via its specific receptor uPAR and the association of uPAR with adaptor proteins on the cell surface, regulates survival/apoptosis processes in human MCs. Using two different apoptotic stimuli, SF medium and HG medium, we show that the association of uPAR with cell-surface proteins is stimulus-specific and results in an anti-apoptotic effect of uPA under growthfactor withdrawal conditions and in a pro-apoptotic effect of uPA under HG conditions. We demonstrate that the anti-apoptotic effect of uPA is mediated by the RGD-dependent integrins, whereas its pro-apoptotic effect is conditioned by the interaction of uPAR with M6P/IGF2R. We show that uPA acts through the MEK/ERK and PI3K/Akt signalling pathways. We report that the uPA/uPAR system regulates survival/apoptosis processes via a mitochondria-dependent mechanism and that BAD protein serves as a downstream molecule. To our knowledge, this is the first study to document a functional link between uPAR-M6P/IGF2R and BAD protein.
Numerous reports have documented that the uPA-uPAR interaction activates ERK and PI3K pathways [30, 31] . The role of integrins in the regulation of cell survival has been well established [32] . In the present study, uPA induced strong activation of ERK 1/2 and Akt under SF conditions, resulting in the anti-apoptotic effect of uPA on MCs. Blocking of integrins with RGD peptide converted the anti-apoptotic effect of uPA into a pro-apoptotic effect, suggesting an important role for the RGD-dependent integrins in this response. We suggest that two mechanisms might be involved. Thus uPA, under SF conditions, could promote the interaction of uPAR with RGD-dependent integrins similar to the reported activation of the uPAR and β1 integrin interaction in response to uPA [33] . Alternatively, uPA itself could engage, through its individual domains, two different surface receptors, namely uPAR and integrin, as reported previously [34] . Under HG conditions, uPA fails to activate ERK and Akt pathways, suggesting a disruption of the uPAR-integrin interaction. Integrin targeting by RGD peptide and EDTA confirmed a minor role of integrin-uPAR functional interference for the pro-apoptotic events and rather suggest an important role for M6P/IGF2R under those conditions. The M6P/IGF2R has been implicated as a growth and tumour suppressor and receptor for rapid induction of apoptosis [26] . In the insulin-secreting cell lines and in the human erythroleukaemia cell line HG enhances presentation of M6P/IGF2R at the cell plasma membrane [35] . Our immunocytochemical studies demonstrate that MCs under SF conditions have a negligible amount of M6P/IGF2R on the cell surface, whereas HG upregulates this receptor. We propose that under HG conditions, uPA induces co-operation between uPAR and M6P/IGF2R resulting in their co-localization on the cell surface and perhaps in delaying their internalization. The mechanism of M6P/IGF2R redistribution to the plasma membrane associated with a decreased internalization has been reported previously [36] . Our experiments using ATF speak in favour of a decreased internalization of uPAR and M6P/IGF2R in MCs under uPA/HG conditions. ATF, which serves as the binding domain for uPA, cannot be internalized, since the catalytic domain of uPA is needed for internalization. In our experiments, ATF, similarly to uPA, induced co-localization of uPAR and M6P/IGF2R on the cell surface under ATF/HG conditions (results not shown). It should be pointed out that ATF completely retained both pro-and antiapoptotic effects of uPA under the conditions used. The results of experiments with ATF presented here emphasize the role of uPA binding to uPAR and consequently the role of uPAR itself in survival/apoptosis processes.
In our experiments on MCs with silenced uPAR, we observed abrogation of the uPA effects. One possible explanation for this observation is that down-regulation of uPAR diminished the association of uPAR with other interacting molecules on the cell surface and the signalling complexes following uPA-uPAR binding were turned off. Interestingly, we noticed that silencing of uPAR markedly up-regulated the basal level of BAD protein and M6P/IGF2R in MCs suggesting that uPAR itself is an antiapoptotic factor. uPAR activation by uPA followed by signalling complex formation in a stimulus-specific fashion, might enable uPAR to operate as a pro-apoptotic factor. The results of the present study demonstrate that BAD is a key signalling molecule, which mediates both pro-apoptotic and anti-apoptotic processes in human MCs in response to uPA. Our results indicate that in MCs, BAD protein acts via at least two different mechanisms: the change of its amount in mitochondria and intracellular redistribution. Under SF conditions, uPA prevented apoptosis by decreasing the amount of BAD in the mitochondrial fraction and no redistribution of BAD was observed. In contrast, under HG conditions uPA induced apoptosis by increasing the amount of BAD in the mitochondrial fraction and BAD was found in a perinuclear region. These findings confirm the recent reports of others, which suggest that, in response to the apoptotic stimulus, subpopulations of mitochondria and some regulatory proteins MCs were nucleofected with non-specific RNA (upper three rows) or siM6P/IGF2R RNA duplexes (lower three rows) followed by incubation with 10 nM uPA in combination with HG or with SF medium for 48 h. BAD protein (green) was visualized by immunostaining with anti-BAD antibody and Alexa Fluor ® 488-conjugated secondary antibodies; mitochondria (red) were visualized by staining with MitoTracker Red (MTR). The merge image is presented in yellow. Cells in 5 % (v/v) FCS-containing culture medium were used as a NC for apoptosis. The images shown are representative of three independent experiments. are mobilized to translocate to the highly metabolically active perinuclear ring, to affect the process of apoptosis [37] .
Overall, the results of the present study support a model in which the uPA/uPAR system via association with other receptors on the cell surface regulates survival/apoptosis processes in MCs in a stimulus-dependent manner. These findings may help to unravel an unexplored link between the uPA/uPAR system and regulation of cell fate upon diabetic nephropathy and may serve as a starting point to the understanding of molecular mechanisms underlying kidney pathology.
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